Helen M. Boudreau

Ms. Boudreau has served as a member of our Board since August 2023. She also serves on the Board of Directors of Premier, Inc., Shattuck Labs, and Rallybio. Ms. Boudreau’s 30-year career spans the biotechnology, pharmaceuticals, consulting, and banking industries. Prior to her retirement, Ms. Boudreau served as the Chief Operating Officer of the Bill & Melinda Gates Medical Research Institute. Previously, she served as Chief Financial Officer (CFO) of Proteostasis Therapeutics and FORMA Therapeutics. Ms. Boudreau spent 16 years at Novartis and Pfizer, where she held roles including CFO of Novartis Corporation in the U.S., global CFO of Novartis Oncology, and senior finance positions at Pfizer Inc. Prior to joining the pharmaceutical sector, she held roles at PepsiCo, McKinsey & Company, and Bank of America. She received a B.A. from the University of Maryland and an MBA from the Darden Graduate School of Business at the University of Virginia.